We are live on ! Find out more
CP

Cumberland Partners Portfolio holdings

AUM $1.32B
1-Year Est. Return 27.83%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+27.83%
3 Year Est. Return
+88.45%
5 Year Est. Return
+120.48%
10 Year Est. Return
+368.85%
AUM
$771M
AUM Growth
-$36.4M
Cap. Flow
-$47.7M
Cap. Flow %
-6.18%
Top 10 Hldgs %
50.55%
Holding
69
New
7
Increased
19
Reduced
29
Closed
9

Top Sells

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$30.1M
2
XRX icon
Xerox
XRX
+$28.3M
3
QCOM icon
Qualcomm
QCOM
+$21.9M
4
MCK icon
McKesson
MCK
+$20.4M
5
BNS icon
Scotiabank
BNS
+$17M

Sector Composition

Rank Sector Weight
1 Financials 35.81%
2 Healthcare 18.62%
3 Consumer Discretionary 16.39%
4 Energy 11.09%
5 Industrials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$935B
$54.4M 7.06%
824,468
-21,125
-2% -$1.38M
AIG icon
2
American International
AIG
$41.7B
$47.4M 6.15%
765,217
-17,850
-2% -$1.09M
TD icon
3
Toronto Dominion Bank
TD
$198B
$43.1M 5.59%
1,098,763
-49,417
-4% -$2M
BAC icon
4
Bank of America
BAC
$435B
$42.3M 5.49%
2,513,783
-46,219
-2% -$782K
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
$37.5M 4.86%
439,990
+172,355
+64% +$14.6M
MITL
6
DELISTED
Mitel Networks Corporation
MITL
$35.3M 4.57%
4,574,845
-27,325
-0.6% -$219K
PHM icon
7
Pultegroup
PHM
$24.1B
$33.5M 4.34%
1,878,900
+318,825
+20% +$5.95M
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$32.3M 4.19%
169,350
-3,195
-2% -$558K
SU icon
9
Suncor Energy
SU
$79.4B
$32M 4.16%
1,241,444
+217,036
+21% +$5.99M
C icon
10
Citigroup
C
$222B
$31.9M 4.14%
617,156
-8,185
-1% -$434K
COF icon
11
Capital One
COF
$128B
$30.3M 3.92%
419,149
+42,798
+11% +$3.28M
WRK
12
DELISTED
WestRock Company
WRK
$30M 3.89%
729,870
+156,912
+27% +$7.14M
QVCGA
13
DELISTED
QVC Group Inc Series A
QVCGA
$28.7M 3.73%
21,659
-388
-2% -$509K
UNP icon
14
Union Pacific
UNP
$174B
$28.1M 3.65%
359,890
-10,040
-3% -$861K
CI icon
15
Cigna
CI
$73.7B
$25.9M 3.36%
+177,200
New +$24.4M
PBA icon
16
Pembina Pipeline
PBA
$28.4B
$25.5M 3.31%
1,171,100
-9,750
-0.8% -$234K
NWL icon
17
Newell Brands
NWL
$2.38B
$24.4M 3.17%
554,050
+163,250
+42% +$7.14M
CVE icon
18
Cenovus Energy
CVE
$55.7B
$23.1M 3%
1,827,736
+516,645
+39% +$7.62M
ENDP
19
DELISTED
Endo International plc
ENDP
$22.2M 2.89%
363,435
+187,100
+106% +$11.4M
AGN
20
DELISTED
Allergan plc
AGN
$21.8M 2.83%
+69,855
New +$20.8M
CCL icon
21
Carnival Corporation Ltd
CCL
$38.1B
$19.9M 2.58%
365,590
-8,310
-2% -$430K
GM icon
22
General Motors
GM
$80.4B
$8.37M 1.09%
246,050
-200
-0.1% -$6.95K
BN icon
23
Brookfield
BN
$104B
$7.39M 0.96%
666,925
+2,278
+0.3% +$26.7K
BIN
24
DELISTED
PROGRESSIVE WASTE SOLUTIONS LTD COM
BIN
$6.47M 0.84%
+274,600
New +$6.55M
TIME
25
DELISTED
Time Inc.
TIME
$5.85M 0.76%
373,575
-860,800
-70% -$14.8M

Similar funds

Cumberland Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Cumberland Partners held 69 positions worth $771M, down 4.5% from $807M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cumberland Partners withdrew a net $47.7M in Q4 2015, closing 9 positions and reducing 29 holdings. Its most notable exit was SANDISK CORP, an estimated $30.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Cumberland Partners opened a new position in Cigna worth $25.9M.

  • Cumberland Partners's largest Q4 2015 buy was Cigna: 177,200 shares worth $25.9M.
  • Cumberland Partners added most to Walgreens Boots Alliance in Q4 2015, an estimated $14.6M increase.
  • Cumberland Partners's biggest Q4 2015 reduction was Scotiabank, cutting an estimated $17M.
  • Cumberland Partners fully exited SANDISK CORP in Q4 2015, selling an estimated $30.1M.
  • Cumberland Partners's ten largest holdings make up 51% of its $771M portfolio in Q4 2015.
  • Cumberland Partners opened 7 new positions and closed 9 in Q4 2015.
  • Cumberland Partners's portfolio value fell 4.5% quarter-over-quarter to $771M.

Based on Cumberland Partners's 13F filing for Q4 2015, filed 28 Jan 2016.